Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 20, Issue 12, 2004, Pages 1293-1297

  Fuster, Daniel ^a   Planas, Ramon ^b   Muga, Robert ^a   Ballesteros, Angel L ^a   Santos, Justiniano ^b   Tor, Jordi ^a   Sirera, Guillem ^a   Guardiola, Helena ^a   Salas, Anna ^a   Cabré, Eduard ^b   Ojanguren, Isabel ^c   Barluenga, Eva ^d   Rey Joly, Celestino ^a   Clotet, Bonaventura ^a   Tural, Cristina ^a  

^a HIV Clinical Unit   (Spain)

^b Hepatol and Gastroenterol Dept

^c Pathology Department

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG USE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; T LYMPHOCYTE; VIRUS LOAD;

EID: 19944429232     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2004.20.1293     Document Type: Article

References (16)

1. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al.: Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-497.
2. Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G, et al.: Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997. Clin Infect Dis 2001;32:1207-1214.
3. Lauer GM and Walker BD: Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
4. Pol S, Lamborthe B, Thi NT, Thiers V, Carnot F, Zylberberg H, et al.: Retrospective analysis of the impact of HIV infection and alcohol abuse on chronic hepatitis C in a large cohort of drug users. J Hepatol 1998;28:945-950.
5. Soto B, Sanchez-Quijano A, Rodrigo L, del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, et al.: Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997;26:1-5.
6. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al.: Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999;30:1054-1058.
7. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, et al.: Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clin Infect Dis 2001;33:562-569.
8. Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, et al.: The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study. Hepatology 2001;34:1193-1199.
9. Benhamou Y, Di Martino V, Bochet M, Colombet G, Thibault V, Liou A, et al.: Factors affecting liver fibrosis in human immunodeficiency virus and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy. Hepatology 2001;34:283-287.
10. Tural C, Fuster D, Tor J, Ojanguren I, Sirera G, Ballesteros AL, et al.: Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) coinfected patients. J Viral Hepatol 2003;10(2):118-125.
11. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C. Hepatology 1997;26(Suppl. 1):2S-10S.
12. Knodell RG, Ishak KG, Black WC, et al.: Formulation and application of a numerical scoring system for assessing activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
13. Sulkowski MS, Thomas DL, Chaisson RE, and Moore RD: Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000;283:74-80.
14. Aguilera A, Losada E, Novoa S, Seone R, Otero L, González-Quintero A, et al.: High prevalence of infection by hepatitis C virus genotype 4 in Northern Spain intravenous drug users with HIV. 2nd IAS, Paris, July 13-16, 2003 [abstract 957].
15. Sterling RK, Contos MJ, Sanyal AJ, Luketíc VA, Stravitz RT, Wilson MS, et al.: The clinical spectrum of hepatitis C virus in HIV infection. J Acquir Immune Defic Syndr 2003;32:30-37.
16. Martínez-Sierra C, Arizcorreta A, Díaz F, Roldán R, Martín-Hererra L, Pérez-Guzmán E, et al.: Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003;36:491-498.